Global Needle Free Injectior Market Research Report 2023

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.



Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.

Highlights

The global Needle Free Injectior market was valued at US$ 206.4 million in 2022 and is anticipated to reach US$ 262.1 million by 2029, witnessing a CAGR of 3.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Needle Free Injectior, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle Free Injectior.

The Needle Free Injectior market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Needle Free Injectior market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Needle Free Injectior manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.


By Company


Zogenix

Inovio

Glide Pharma

Akra Dermojet

Crossject Medical Technology

Injex Pharma

Eternity Healthcare

Antares Pharma

Valeritas

Medical International Technologies

Penjet

PharmaJet

National Medical Products

Activa Brand Products


Segment by Type


Prefilled Needle Free Injector

Fillable Needle Free Injector


Segment by Application


Drug Injection Use

Cosmetic Surgery Use

Others


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Needle Free Injectior manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Needle Free Injectior in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.